Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Accuracy of Ultrasound Biomarkers for Assessing Eligibility and Response to Resmetirom Therapy Using MRI as the Reference Standard

NCT07860814 is registered in ClinicalTrials.gov with Radnet Management, Inc. as lead sponsor.

NCT NCT07860814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07860814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Accuracy of Ultrasound Biomarkers for Assessing Eligibility and Response to Resmetirom Therapy Using MRI as the Reference Standard
Lead sponsor
Radnet Management, Inc.
Phase
Observational
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
October 31, 2030
Enrollment
524 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-steatohepatitis (mash)